Health-Related Quality of Life of Patients with Marfan Syndrome—Polish Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Assessment
2.3. Organization and the Course of the Study
3. Results
4. Discussion
5. Conclusions
- The quality of life of people with MFS is lower in comparison with the quality of life of healthy people.
- In organizing help for patients with MFS, attention should be paid to the differentiations in terms of gender, which was not found in the healthy group.
- Patients’ beliefs about the impact of cardiac symptoms on their life is very important, and it should be the basis of medical evaluation, treatment, rehabilitation, and psychoeducational programs.
- Psychological evaluation of patients for anxiety and depression and pain management and fatigue should be included, as research shows that these are important factors in the quality of life of patients.
- It is worthwhile to search for the causes of fatigue and its relationship with reduced exercise tolerance, which will allow for the design of a patient care strategy.
- The development of psycho-educational intervention programs may improve the quality of social support, and this in turn may affect the lowering bio-behavioral factors such as depression, which would constitute a good strategy for the improvement of the quality of life of the patients with Marfan syndrome.
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wozniak-Mielczarek, L.; Sabiniewicz, R.; Drezek-Nojowicz, M.; Nowak, R.; Gilis-Malinowska, N.; Mielczarek, M.; Łabuc, A.; Waldoch, A.; Wierzba, J. Differences in Cardiovascular Manifestation of Marfan Syndrome Between Children and Adults. Pediatr. Cardiol. 2018, 40, 393–403. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Laganà, G.; Laganà, G.; Venza, N.; Malara, A.; Liguori, C.; Cozza, P.; Pisano, C. Obstructive sleep apnea, palatal morphology, and aortic dilatation in Marfan syndrome growing subjects: A retrospective study. Int. J. Environ. Res. Public Health 2021, 18, 3045. [Google Scholar] [CrossRef] [PubMed]
- Woźniak, L.; Sabiniewicz, R.; Wałdoch, A. Zespół Marfana. Stand. Med. Pediatr. 2016, 12, 112–116. [Google Scholar]
- Passarge, E. Genetyka; Wydawnictwo Lekarskie PZWL: Warszawa, Poland, 2004. [Google Scholar]
- Chiu, H.-H.; Wu, M.-H.; Chen, H.-C.; Kao, F.-Y.; Huang, S.-K. Epidemiological Profile of Marfan Syndrome in a General Population: A National Database Study. Mayo Clin. Proc. 2014, 89, 34–42. [Google Scholar] [CrossRef]
- Gray, J.R.; Bridges, A.B.; Faed, M.J.; Pringle, T.; Baines, P.; Dean, J.; Boxer, M. Ascertainment and severity of Marfan syndrome in a Scottish population. J. Med. Genet. 1994, 31, 51–54. [Google Scholar] [CrossRef] [Green Version]
- Groth, K.A.; Hove, H.; Kyhl, K.; Folkestad, L.; Gaustadnes, M.; Vejlstrup, N.; Stochholm, K.; Østergaard, J.R.; Andersen, N.H.; Gravholt, C. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J. Rare Dis. 2015, 10, 153. [Google Scholar] [CrossRef] [Green Version]
- Benninghoven, D.; Hamann, D.; Von Kodolitsch, Y.; Rybczynski, M.; Lechinger, J.; Schroeder, F.; Vogler, M.; Hoberg, E. Inpatient rehabilitation for adult patients with Marfan syndrome: An observational pilot study. Orphanet J. Rare Dis. 2017, 12, 127. [Google Scholar] [CrossRef] [Green Version]
- De Bie, S.; de Paepe, A.; Delvaux, I.; Davies, S.; Hennekam, R.C.M. Marfan Syndrome in Europe. Public Health Genom. 2004, 7, 216–225. [Google Scholar] [CrossRef]
- Foran, J.R.H.; Pyeritz, R.E.; Dietz, H.C.; Sponseller, P.D. Characterization of the symptoms associated with dural ectasia in the Marfan patient. Am. J. Med. Genet. 2005, 134A, 58–65. [Google Scholar] [CrossRef]
- Fusar-Poli, P.; Klersy, C.; Stramesi, F.; Callegari, A.; Arbustini, E.; Politi, P. Determinants of Quality of Life in Marfan Syndrome. Psychosomatics 2008, 49, 243–248. [Google Scholar] [CrossRef]
- Goldfinger, J.Z.; Preiss, L.R.; Devereux, R.B.; Roman, M.J.; Hendershot, T.P.; Kroner, B.L.; Eagle, K.A. Marfan Syndrome and Quality of Life in the GenTAC Registry. J. Am. Coll. Cardiol. 2017, 69, 2821–2830. [Google Scholar] [CrossRef]
- Moon, J.R.; Cho, Y.A.; Huh, J.; Kang, I.-S.; Kim, D.-K. Structural equation modeling of the quality of life for patients with marfan syndrome. Health Qual. Life Outcomes 2016, 14, 83. [Google Scholar] [CrossRef] [Green Version]
- Peters, K.; Apse, K.; Blackford, A.; McHugh, B.; Michalic, D.; Biesecker, B. Living with Marfan syndrome: Coping with stigma. Clin. Genet. 2005, 68, 6–14. [Google Scholar] [CrossRef]
- Peters, K.; Kong, F.; Hanslo, M.; Biesecker, B.B. Living with Marfan syndrome III. Quality of life and reproductive planning. Clin. Genet. 2002, 62, 110–120. [Google Scholar]
- Peters, K.; Kong, F.; Horne, R.; Francomano, C.; Biesecker, B. Living with Marfan syndrome I. Perceptions of the condition. Clin. Genet. 2001, 60, 273–282. [Google Scholar] [CrossRef]
- Rand-Hendriksen, S.; Johansen, H.; Semb, S.O.; Geiran, O.; Stanghelle, J.K.; Finset, A. Health-related quality of life in Marfan syndrome: A cross-sectional study of Short Form 36 in 84 adults with a verified diagnosis. Genet. Med. 2010, 12, 517–524. [Google Scholar] [CrossRef] [Green Version]
- Ratiu, I.; Virden, T.B.; Baylow, H.; Flint, M.; Esfandiarei, M. Executive function and quality of life in individuals with Marfan syndrome. Qual. Life Res. 2018, 27, 2057–2065. [Google Scholar] [CrossRef]
- Schoormans, D.; Radonic, T.; De Witte, P.; Groenink, M.; Azim, D.; Lutter, R.; Mulder, B.J.M.; Sprangers, M.A.G.; Zwinderman, A.H. Mental quality of life is related to a cytokine genetic pathway. PLoS ONE 2012, 7, e45126. [Google Scholar] [CrossRef] [Green Version]
- Speed, T.J.; Mathur, V.; Hand, M.; Christensen, B.; Sponseller, P.D.; Williams, K.A.; Campbell, C.M. Characterization of pain, disability, and psychological burden in Marfan syndrome. Am. J. Med. Genet. 2017, 173, 315–323. [Google Scholar] [CrossRef]
- Stanišić, M.-G.; Rzepa, T.; Gawrońska, A.; Kubaszewski, P.; Putowski, M.; Stefaniak, S.; Perek, B. Personal resources and satisfaction with life in Marfan syndrome patients with aortic pathology and in abdominal aortic aneurysm patients. Kardiochir. Torakochirurg. Pol. 2018, 15, 27–30. [Google Scholar] [CrossRef]
- Velvin, G.; Rand-Hendriksen, S.; Geirdal, A. Satisfaction with life in adults with Marfan syndrome (MFS): Associations with health-related consequences of MFS, pain, fatigue, and demographic factors. Qual. Life Res. 2016, 25, 1779–1790. [Google Scholar] [CrossRef] [PubMed]
- Żołnierczyk-Zreda, D. Polska Wersja Kwestionariusza SF-36v2 do Badania Jakości Życia; Centralny Instytut Ochrony Pracy—Państwowy Instytut Badawczy: Warszawa, Poland, 2009. [Google Scholar]
- Marcinowicz, L.; Sienkiewicz, J. Badanie trafności i rzetelności polskiej wersji kwestionariusza SF-36: Wyniki wstępne. Przegl. Lek. 2003, 60, 103–106. [Google Scholar] [PubMed]
- Loeys, B.L.; Dietz, H.C.; Braverman, A.C.; Callewaert, B.L.; De Backer, J.; Devereux, R.B.; Hilhorst-Hofstee, Y.; Jondeau, G.; Faivre, L.; Milewicz, D.M.; et al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 2010, 47, 476–485. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Andonian, C.; Freilinger, S.; Achenbach, S.; Ewert, P.; Gundlach, U.; Kaemmerer, H.; Beckmann, J. Quality of life in patients with Marfan syndrome: A cross-sectional study of 102 adult patients. Cardiovasc. Diagn. Ther. 2021, 11, 602. [Google Scholar] [CrossRef] [PubMed]
- Sumalla, E.C.; Ochoa, C.; Blanco, I. Posttraumatic growth in cancer: Reality or illusion? Clin. Psychol. Rev. 2009, 29, 24–33. [Google Scholar] [CrossRef]
- Thijssen, C.G.; Doze, D.E.; Gökalp, A.L.; Timmermans, J.; Peters, J.B.; Elbers-van de Ven, L.H.; van Kimmenade, R.R. Male-female differences in quality of life and coping style in patients with Marfan syndrome and hereditary thoracic aortic diseases. J. Genet. Couns. 2020, 29, 1259–1269. [Google Scholar] [CrossRef]
- Zdun-Ryżewska, A.; Majkowicz, M. Ból i depresja. In Ból Przewlekły. Ujęcie Kliniczne i Psychologiczne; Leppert, W., Majkowicz, M., Eds.; PZWL: Warszawa, Poland, 2018; pp. 114–132. [Google Scholar]
- Basiński, K. Ból dolnego odcinka kręgosłupa—Perspektywa bio-psycho-społeczna. In Ból Przewlekły. Ujęcie Kliniczne i Psychologiczne; Leppert, W., Majkowicz, M., Eds.; PZWL: Warszawa, Poland, 2018; pp. 133–140. [Google Scholar]
- Brown, R.L.; Barrett, A.E. Visual impairment and quality of life among older adults: An examination of explanations for the relationship. J. Gerontol. B Psychol. Sci. Soc. Sci. 2011, 66, 364–373. [Google Scholar] [CrossRef] [Green Version]
- Iecovich, E.; Isralowitz, R.E. Visual impairments, functional and health status, and life satisfaction among elderly bedouins in Israel. Ageing Int. 2004, 29, 71–87. [Google Scholar] [CrossRef]
- Lazon de la Jara, P.; Erickson, D.; Erickson, P.; Stapleton, F. Visual and non-visual factors associated with patient satisfaction and quality of life in LASIK. Eye 2011, 25, 1194–1201. [Google Scholar] [CrossRef] [Green Version]
- Verbraecken, J.; Erickson, D.; Stapleton, F. Evaluation for sleep apnea in patients with Ehlers–Danlos syndrome and Marfan: A questionnaire study. Clin. Genet. 2001, 60, 360–365. [Google Scholar] [CrossRef]
- Nielsen, C.; Ratiu, I.; Esfandiarei, M.; Chen, A.; Tierney, E.S.S. A review of psychosocial factors of Marfan Syndrome: Adolescents, adults, families, and providers. J. Pediatr. Gen. 2019, 8, 109–122. [Google Scholar] [CrossRef]
Variable | People with Marfan Syndrome (N = 35) | Healthy People (N = 33) | ||
---|---|---|---|---|
M | SD | M | SD | |
Age | 32.68 | 11.97 | 33.03 | 11.95 |
N | % | N | % | |
Sex: | ||||
Women | 21 | 60 | 21 | 63.64 |
Men | 14 | 40 | 12 | 36.36 |
Professional activity: | ||||
Professionally active | 11 | 31.43 | 5 | 15.15 |
Professionally inactive | 23 | 65.71 | 26 | 78.79 |
Education: | ||||
Basic or vocational | 3 | 5.57 | 1 | 3.03 |
Secondary | 16 | 45.71 | 11 | 33.33 |
Higher | 15 | 42.86 | 20 | 60.61 |
Residence: | ||||
Village | 10 | 28.57 | 2 | 6.06 |
Town > 30,000 inhabitants | 6 | 17.14 | 5 | 15.15 |
City 30,000–100,000 inhabitants | 8 | 22.86 | 7 | 21.21 |
City over 100,000 inhabitants | 10 | 28.57 | 17 | 51.51 |
Relationship: | ||||
People in a steady relationship | 20 | 57.14 | 21 | 63.64 |
People not in a relationship | 14 | 40 | 9 | 27.27 |
Financial situation | ||||
Above the average | 9 | 25.71 | 21 | 63.63 |
Average | 19 | 54.26 | 10 | 30.30 |
Rather bad or bad | 5 | 2.86 | 1 | 3.03 |
Membership of Marfan Poland Association | ||||
Yes | 18 | 60 | ||
No | 12 | 40 |
Variable | Number |
---|---|
Marfan syndrome: | |
de novo | 7 |
familial | 15 |
Aorta condition: | |
Dissected aorta | 19 |
Non-dissected aorta | 8 |
Result from the upper part of the norm | 2 |
Dissection or rupture of aneurysm | 3 |
The course of the disease: | |
With a cardiac surgery | 7 |
Without a cardiac surgery | 21 |
Ghent Criteria | M |
---|---|
Total number of points in Ghent scale | 7.63 |
n | |
Thumb or wrist symptoms: | |
Thumb symptom | 22 |
Wrist symptom | 19 |
Symptoms connected with chest: | |
Pigeon chest | 16 |
Pectus excavatum | 8 |
Chest asymmetry | 22 |
Symptoms connected with feet: | |
Metatarsal deformation | 7 |
Flat foot | 14 |
Both criteria fulfilled | 5 |
Pneumothroax | 1 |
Reduced relation of the upper body part to the lower part, increased relation of the arms span to the height with the absence of scoliosis USLS < 85 | 28 |
Scoliosis, kyphosis | 26 |
Limited strengthening of an elbow (<170°) | 3 |
Dysmorphic facial features (≥3 z 5) | 14 |
Stretch marks | 16 |
Myopia > 3 Dioptres | 17 |
Mitral valve prolapse | 20 |
Quality of Life Conditioned by the Health Status (SF-36) | Marfan Syndrome | Healthy People | Significance of Differences | 95% CI | ||||
---|---|---|---|---|---|---|---|---|
M | SD | M | SD | t | p | LL | UL | |
PF | 74.85 | 16.93 | 93.03 | 9.60 | −5.37 | 0.000 | −24.95 | −11.41 |
RP | 56.82 | 37.64 | 83.33 | 27.72 | −3.26 | 0.002 | −42.77 | −10.26 |
BP | 54.88 | 21.33 | 57.58 | 23.15 | −0.49 | 0.625 | −13.64 | 8.25 |
GH | 29.85 | 19.54 | 53.18 | 17.85 | −5.06 | 0.000 | −32.54 | −14.13 |
VT | 53.03 | 14.57 | 60.91 | 18.81 | −1.90 | 0.062 | −16.15 | 0.40 |
SE | 71.21 | 18.88 | 62.88 | 25.09 | 1.52 | 0.132 | −2.59 | 19.25 |
RE | 69.70 | 40.28 | 81.82 | 34.45 | −1.31 | 0.194 | −30.55 | 6.31 |
MH | 64.97 | 14.66 | 69.21 | 14.19 | −1.19 | 0.237 | −11.34 | 2.85 |
PCS | 49.15 | 8.41 | 58.76 | 6.49 | −5.20 | 0.000 | −13.30 | −5.91 |
MCS | 48.64 | 7.06 | 50.97 | 8.40 | −1.22 | 0.226 | −6.15 | 1.48 |
GS SF-36 | 97.79 | 14.06 | 109.73 | 13.86 | −3.47 | 0.000 | −18.81 | −5.07 |
Quality of Life Conditioned by the Health Status (SF-36) | Marfan Syndrome | Healthy People | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
K | M | Significance of Differences | K | M | Significance of Differences | |||||||
M | SD | M | SD | t | p | M | SD | M | SD | t | p | |
PF | 66.50 | 13.19 | 87.69 | 13.94 | −4.41 | 0.000 | 91.43 | 9.24 | 95.83 | 9.96 | −1.28 | 0.210 |
RP | 57.50 | 34.51 | 55.77 | 43.49 | 0.13 | 0.900 | 80.95 | 27.28 | 87.50 | 29.19 | −0.65 | 0.523 |
BP | 55.56 | 23.08 | 53.85 | 19.16 | 0.22 | 0.826 | 54.50 | 20.76 | 62.96 | 26.94 | −1.01 | 0.320 |
GH | 24.25 | 17.34 | 38.46 | 20.25 | −2.15 | 0.039 | 52.62 | 16.25 | 54.17 | 21.09 | −0.24 | 0.815 |
VT | 46.50 | 10.27 | 63.08 | 14.80 | −3.81 | 0.001 | 59.76 | 18.20 | 59.76 | 18.20 | −0.46 | 0.650 |
SE | 69.38 | 20.06 | 65.00 | 43.90 | −0.69 | 0.497 | 59.76 | 18.20 | 69.79 | 18.04 | −1.21 | 0.237 |
RE | 65.00 | 43.90 | 76.92 | 34.39 | −0.83 | 0.415 | 77.78 | 37.02 | 88.89 | 29.59 | −0.89 | 0.381 |
MH | 60.20 | 15.65 | 72.31 | 9.45 | −2.50 | 0.018 | 68.00 | 15.28 | 71.33 | 12.40 | −0.64 | 0.525 |
PCS | 46.45 | 6.99 | 53.31 | 8.97 | −2.46 | 0.020 | 57.95 | 5.67 | 60.17 | 7.78 | −0.94 | 0.354 |
MCS | 45.85 | 6.29 | 52.92 | 6.13 | −3.19 | 0.003 | 50.00 | 9.31 | 52.67 | 6.54 | −0.87 | 0.389 |
GS SF-36 | 92.30 | 11.20 | 106.23 | 14.19 | −3.14 | 0.004 | 107.95 | 14.40 | 112.83 | 12.87 | −0.97 | 0.339 |
SF-36 | PF | RP | BP | GH | VT | SE | RE | MH | PCS | MCS | GS SF-36 |
---|---|---|---|---|---|---|---|---|---|---|---|
Orthopedic problems | −0.72 ** | −0.10 | 0.17 | −0.58 * | −0.71 * | −0.54 * | −0.51 | −0.52 * | −0.61 * | −0.76 ** | −0.73 * |
Ophthalmic problems | −0.34 | 0.05 | 0.31 | −0.39 | −0.57 * | −0.19 | −0.20 | −0.15 | −0.21 | −0.46 | −0.36 |
Cardiological problems | −0.37 | −0.61 * | 0.07 | −0.33 | −0.11 | −0.19 | −0.49 | −0.28 | −0.42 | −0.35 | −0.41 |
Lower exercise tolerance | −0.52 * | −0.68 * | −0.23 | −0.34 | −0.39 | −0.54 * | −0.34 | −0.20 | −0.56 * | −0.49 | −0.56 * |
SF-36 | PF | RP | BP | GH | VT | SE | RE | MH | PCS | MCS | GS SF-36 |
---|---|---|---|---|---|---|---|---|---|---|---|
Number of Ghent points | −0.07 | 0.17 | 0.19 | −0.35 | −0.33 | 0.00 | −0.21 | −0.14 | −0.20 | −0.13 | −0.18 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Trawicka, A.; Lewandowska-Walter, A.; Majkowicz, M.; Sabiniewicz, R.; Woźniak-Mielczarek, L. Health-Related Quality of Life of Patients with Marfan Syndrome—Polish Study. Int. J. Environ. Res. Public Health 2022, 19, 6827. https://doi.org/10.3390/ijerph19116827
Trawicka A, Lewandowska-Walter A, Majkowicz M, Sabiniewicz R, Woźniak-Mielczarek L. Health-Related Quality of Life of Patients with Marfan Syndrome—Polish Study. International Journal of Environmental Research and Public Health. 2022; 19(11):6827. https://doi.org/10.3390/ijerph19116827
Chicago/Turabian StyleTrawicka, Agnieszka, Aleksandra Lewandowska-Walter, Mikołaj Majkowicz, Robert Sabiniewicz, and Lidia Woźniak-Mielczarek. 2022. "Health-Related Quality of Life of Patients with Marfan Syndrome—Polish Study" International Journal of Environmental Research and Public Health 19, no. 11: 6827. https://doi.org/10.3390/ijerph19116827
APA StyleTrawicka, A., Lewandowska-Walter, A., Majkowicz, M., Sabiniewicz, R., & Woźniak-Mielczarek, L. (2022). Health-Related Quality of Life of Patients with Marfan Syndrome—Polish Study. International Journal of Environmental Research and Public Health, 19(11), 6827. https://doi.org/10.3390/ijerph19116827